Tuberculosis Infections of the Central Nervous System

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 4, 2011-12 ,pp. : 321-327

Bentham Science Publishers

Access to resources Recommend Favorite

Natalizumab: First report of primary central nervous system lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment

By  

Current Pharmaceutical Design, Vol. 17, Iss. 27, 2011-09 ,pp. : 2940-2947

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Small Molecule Tuberculostats for Targeting Tuberculosis Infections of the Central Nervous System

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 1, 2012-03 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite

Cladribine/rituximab: First report of adenocarcinoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1079, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite